Experts Propose Regional Bioequivalence Testing Framework
Stakeholders in Ethiopia aim to boost local generic drug production through a new regional testing strategy.
Updated on Oct. 24, 2026 in Biotech
Live Poll
Do you believe localizing pharmaceutical manufacturing in your region will make medicine more affordable?
Industry experts and officials have concluded a workshop in Addis Ababa to establish a regional framework for bioequivalence testing across Eastern and Southern Africa. This initiative seeks to decrease reliance on overseas testing facilities for generic medicines.
Why it matters
Currently, manufacturers face significant regulatory delays and high costs because they depend on external facilities for bioequivalence verification. Developing domestic capacity aims to ensure that locally manufactured generic medicines are safe, accessible, and scientifically proven.
The workshop spanned a 5-day period in Addis Ababa to address the technical infrastructure gaps. Participants evaluated requirements for establishing shared regional testing capacity with oversight mechanisms.
The players
Intergovernmental Authority on Development
This is a regional trade bloc in Africa that works to foster development and promote peace and security among its member states.
World Bank
This international financial institution provides loans and grants to the governments of low- and middle-income countries for the purpose of pursuing capital projects.
Ethiopian government
The national administration of Ethiopia is responsible for coordinating with regional partners to enhance pharmaceutical manufacturing and health standards.
The details
Experts proposed the implementation of phased, risk-based compliance pathways specifically tailored for legacy pharmaceutical products. By building localized testing infrastructure, stakeholders hope to streamline regional regulatory approvals and improve the production landscape for essential medications.
Timeline
The workshop began on October 19, 2026.
The regional bioequivalence workshop concluded on October 23, 2026.
The Tech Race
The proposal follows a pattern set by the East African Community (EAC) Medicines Regulatory Harmonization initiative in expanding regional health cooperation. This shift seeks to replace fragmented, costly international dependencies with an integrated, self-sustaining technological ecosystem.
A localized testing framework could reduce the cost and improve the availability of essential generic drugs for patients across the region. Streamlined regulatory processes are intended to bring needed medications to market faster and more reliably.
The takeaway
Establishing regional testing capacity is a critical step for African nations seeking self-sufficiency in healthcare production. Implementing these standards helps bridge the gap between imported health technology and local manufacturing capabilities.
Further reading
Learn more about the latest innovations in Biotech.
Live Poll
Do you believe localizing pharmaceutical manufacturing in your region will make medicine more affordable?
